Vericel Stock (NASDAQ: VCEL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 444.634K |
Day Range | - - - |
52 Wk Range | 29.235 - 53.050 |
Market Cap | $2.199B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 14.57% |
Days to Cover | 7.58 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vericel (NASDAQ: VCEL) through any online brokerage.
Other companies in Vericel’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), TG Therapeutics (NASDAQ:TGTX) and PTC Therapeutics (NASDAQ:PTCT).
The latest price target for Vericel (NASDAQ: VCEL) was reported by Truist Securities on Tuesday, March 26, 2024. The analyst firm set a price target for 54.00 expecting VCEL to rise to within 12 months (a possible 18.81% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Vericel (NASDAQ: VCEL) is $45.45 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Vericel.
Vericel’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Vericel.
Vericel is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.